Pre-test video education for Prostate Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Prostate Cancer+1 More
Pre-test video education - Other
Eligibility
18+
Male
What conditions do you have?
Select

Study Summary

This trial is testing whether pre-test video education and post-test genetic counseling is as effective as in-person pre-test genetic counseling for males with advanced prostate cancer.

Eligible Conditions
  • Prostate Cancer

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Prostate Cancer

Study Objectives

1 Primary · 7 Secondary · Reporting Duration: 2 years

Month 4
Family communication for those who tested positive for a genetic mutation
Multidimensional Impact of Cancer Risk Assessment score and subscales
2 years
Genetic testing uptake
Prevalence of germline mutations in males with prostate cancer
Secondary or other primary (non-prostate) malignancies
4 months post-result disclosure
Knowledge of multigene panel testing score
Month 1
Genetic testing satisfaction score
pre-result disclosure
Intent to disclose genetic test results

Trial Safety

Safety Progress

1 of 3

Other trials for Prostate Cancer

Trial Design

2 Treatment Groups

Traditional pre-test genetic counseling
1 of 2
Pre-test video education
1 of 2
Active Control
Experimental Treatment

662 Total Participants · 2 Treatment Groups

Primary Treatment: Pre-test video education · No Placebo Group · N/A

Pre-test video education
Other
Experimental Group · 1 Intervention: Pre-test video education · Intervention Types: Other
Traditional pre-test genetic counseling
Other
ActiveComparator Group · 1 Intervention: Traditional pre-test genetic counseling · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 2 years

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor
1,012 Previous Clinical Trials
392,697 Total Patients Enrolled
67 Trials studying Prostate Cancer
15,884 Patients Enrolled for Prostate Cancer
Barbara Ann Karmanos Cancer InstituteOTHER
159 Previous Clinical Trials
7,898 Total Patients Enrolled
14 Trials studying Prostate Cancer
409 Patients Enrolled for Prostate Cancer
University of Texas Southwestern Medical CenterOTHER
943 Previous Clinical Trials
605,520 Total Patients Enrolled
15 Trials studying Prostate Cancer
1,473 Patients Enrolled for Prostate Cancer
Huma Q Rana, MDPrincipal InvestigatorDana-Farber Cancer Institute
1 Previous Clinical Trials
1,200 Total Patients Enrolled
1 Trials studying Prostate Cancer
1,200 Patients Enrolled for Prostate Cancer

Eligibility Criteria

Age 18+ · Male Participants · 7 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
Persistent PSA after prostatectomy for PSA ≥ 0.
You have had a prostatectomy or radiation therapy with a PSA doubling time of ≤ 6 months.
You have metastatic prostate cancer.
You have localized prostate cancer with Gleason score ≥8.
You have prostate cancer diagnosed at age ≤ 55 years.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 18th, 2021

Last Reviewed: October 25th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.